Catalyst Wire Dossier Catalyst Wire Dossier

Remimazolam Tosilate

remimazolam · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Remimazolam Tosilate, covering 2015-12-31 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Remimazolam Tosilate for Sedation in the ICU [Phase 3]

See pricing